Study: NCT05351749

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: New-prescription Alert
Description: An enhanced drug alert notification in the Michigan Medicine electronic health record (EHR) that is tailored to the specific type of inappropriate Direct Oral Anticoagulant (DOAC) use (e.g., dosing too high for renal dysfunction) and offers decision support to the prescriber to alter a newly prescribed DOAC prescription.

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: New-prescription Alert
Description: An enhanced drug alert notification in the Michigan Medicine electronic health record (EHR) that is tailored to the specific type of inappropriate Direct Oral Anticoagulant (DOAC) use (e.g., dosing too high for renal dysfunction) and offers decision support to the prescriber to alter a newly prescribed DOAC prescription.

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: New-prescription Alert with referral option
Description: An enhanced drug alert notification in the EHR that is tailored to the specific type of inappropriate DOAC use (e.g., dosing too high for renal dysfunction) and offers decision support to the prescriber to alter new DOAC prescription. This alert will ALSO include an option for referral to the anticoagulation clinic pharmacist for assistance.

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: New-prescription Alert with referral option
Description: An enhanced drug alert notification in the EHR that is tailored to the specific type of inappropriate DOAC use (e.g., dosing too high for renal dysfunction) and offers decision support to the prescriber to alter new DOAC prescription. This alert will ALSO include an option for referral to the anticoagulation clinic pharmacist for assistance.

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Existing-prescription notification to prescriber
Description: Prescriber receives a notification through the EHR indicating an existing DOAC prescription may not be appropriate (e.g. due to renal function change, new drug-drug interactions), and recommending a prescription update.

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Existing-prescription notification to prescriber
Description: Prescriber receives a notification through the EHR indicating an existing DOAC prescription may not be appropriate (e.g. due to renal function change, new drug-drug interactions), and recommending a prescription update.

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Existing-prescription notification to pharmacist
Description: Pharmacist receives a notification through the EHR indicating an existing DOAC prescription may not be appropriate (e.g. due to renal function change, new drug-drug interactions), and recommending a prescription update.

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Existing-prescription notification to pharmacist
Description: Pharmacist receives a notification through the EHR indicating an existing DOAC prescription may not be appropriate (e.g. due to renal function change, new drug-drug interactions), and recommending a prescription update.